Johan van der Schoot

3PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 19, 2023
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters

|Sep 07, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering.

Johan M S van der Schoot, Felix L Fennemann, Michael Valente

|May 15, 2019
ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation.

Luis J Cruz, Paul J Tacken, Johan M S van der Schoot

Pageof 1